 Major Histocompatibility Complex
"Major Histocompatibility Complex" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The genetic region which contains the loci of genes which determine the structure of the serologically defined (SD) and lymphocyte-defined (LD) TRANSPLANTATION ANTIGENS, genes which control the structure of the IMMUNE RESPONSE-ASSOCIATED ANTIGENS, HUMAN; the IMMUNE RESPONSE GENES which control the ability of an animal to respond immunologically to antigenic stimuli, and genes which determine the structure and/or level of the first four components of complement.
| Descriptor ID |
D008285
|
| MeSH Number(s) |
G05.360.340.024.340.610 G05.360.340.024.380.500 G12.500.500
|
| Concept/Terms |
Major Histocompatibility Complex- Major Histocompatibility Complex
- Complex, Major Histocompatibility
- Complices, Major Histocompatibility
- Histocompatibility Complex, Major
- Histocompatibility Complices, Major
- Major Histocompatibility Complices
- Histocompatibility Complex
- Complex, Histocompatibility
- Complices, Histocompatibility
- Histocompatibility Complices
|
Below are MeSH descriptors whose meaning is more general than "Major Histocompatibility Complex".
Below are MeSH descriptors whose meaning is more specific than "Major Histocompatibility Complex".
This graph shows the total number of publications written about "Major Histocompatibility Complex" by people in this website by year, and whether "Major Histocompatibility Complex" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 4 | 1 | 5 | | 1981 | 2 | 0 | 2 | | 1982 | 1 | 1 | 2 | | 1983 | 2 | 1 | 3 | | 1984 | 3 | 0 | 3 | | 1986 | 1 | 0 | 1 | | 1989 | 0 | 1 | 1 | | 1990 | 0 | 1 | 1 | | 1991 | 1 | 2 | 3 | | 1992 | 0 | 1 | 1 | | 1993 | 1 | 0 | 1 | | 1994 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 3 | 5 | | 2000 | 0 | 3 | 3 | | 2001 | 1 | 0 | 1 | | 2003 | 1 | 2 | 3 | | 2004 | 3 | 1 | 4 | | 2005 | 2 | 0 | 2 | | 2006 | 3 | 2 | 5 | | 2007 | 3 | 1 | 4 | | 2008 | 2 | 0 | 2 | | 2009 | 3 | 2 | 5 | | 2010 | 1 | 0 | 1 | | 2011 | 0 | 2 | 2 | | 2012 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2015 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Major Histocompatibility Complex" by people in Profiles.
-
Parello CS, Huseby ES. Indoctrinating T cells to attack pathogens through homeschooling. Trends Immunol. 2015 Jun; 36(6):337-43.
-
Keck S, Schmaler M, Ganter S, Wyss L, Oberle S, Huseby ES, Zehn D, King CG. Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14852-7.
-
Daniels KA, Hatfield SD, Welsh RM, Brehm MA. MHC basis of T cell-dependent heterologous immunity to arenaviruses. Virology. 2014 Sep; 464-465:213-7.
-
Vanguri V, Govern CC, Smith R, Huseby ES. Viral antigen density and confinement time regulate the reactivity pattern of CD4 T-cell responses to vaccinia virus infection. Proc Natl Acad Sci U S A. 2013 Jan 2; 110(1):288-93.
-
Shi JQ, Chen J, Wang BR, Zhu YW, Xu Y, Wang J, Xiao H, Shi JP, Zhang YD, Xu J. Short amyloid-beta immunogens show strong immunogenicity and avoid stimulating pro-inflammatory pathways in bone marrow-derived dendritic cells from C57BL/6J mice in vitro. Peptides. 2011 Aug; 32(8):1617-25.
-
Moysey RK, Li Y, Paston SJ, Baston EE, Sami MS, Cameron BJ, Gavarret J, Todorov P, Vuidepot A, Dunn SM, Pumphrey NJ, Adams KJ, Yuan F, Dennis RE, Sutton DH, Johnson AD, Brewer JE, Ashfield R, Lissin NM, Jakobsen BK. High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation. Protein Cell. 2010 Dec; 1(12):1118-27.
-
O'Connor SL, Lhost JJ, Becker EA, Detmer AM, Johnson RC, Macnair CE, Wiseman RW, Karl JA, Greene JM, Burwitz BJ, Bimber BN, Lank SM, Tuscher JJ, Mee ET, Rose NJ, Desrosiers RC, Hughes AL, Friedrich TC, Carrington M, O'Connor DH. MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques. Sci Transl Med. 2010 Mar 10; 2(22):22ra18.
-
Pino S, Brehm MA, Covassin-Barberis L, King M, Gott B, Chase TH, Wagner J, Burzenski L, Foreman O, Greiner DL, Shultz LD. Development of novel major histocompatibility complex class I and class II-deficient NOD-SCID IL2R gamma chain knockout mice for modeling human xenogeneic graft-versus-host disease. Methods Mol Biol. 2010; 602:105-17.
-
Seddon JM, Berggren KT, Fleeman LM. Evolutionary history of DLA class II haplotypes in canine diabetes mellitus through single nucleotide polymorphism genotyping. Tissue Antigens. 2010 Mar; 75(3):218-26.
-
Driver JP, Scheuplein F, Chen YG, Grier AE, Wilson SB, Serreze DV. Invariant natural killer T-cell control of type 1 diabetes: a dendritic cell genetic decision of a silver bullet or Russian roulette. Diabetes. 2010 Feb; 59(2):423-32.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|